about
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinomaRedox mechanisms in hepatic chronic wound healing and fibrogenesisFibrogenesis: Mechanisms, Dynamics and Clinical ImplicationsPotential role of thymosin Beta 4 in liver fibrosisThe wound healing, chronic fibrosis, and cancer progression triadAngiogenesis and liver fibrosisModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsDecrease of PECAM-1-gene-expression induced by proinflammatory cytokines IFN-gamma and IFN-alpha is reversed by TGF-beta in sinusoidal endothelial cells and hepatic mononuclear phagocytesInhibition of tyrosine kinase receptor Tie2 reverts HCV-induced hepatic stellate cell activationAssessment of liver viscoelasticity by using shear waves induced by ultrasound radiation forceNoninvasive tools to assess hepatic fibrosis: ready for prime time?Arg-gly-asp-mannose-6-phosphate inhibits activation and proliferation of hepatic stellate cells in vitro.An earthworm protease cleaving serum fibronectin and decreasing HBeAg in HepG2.2.15 cells.Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosisHepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesisSerum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver diseaseThe therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation.Involvement of cholangiocyte proliferation in biliary fibrosis.Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligationMolecular pathogenesis of hepatic fibrosis and current therapeutic approaches.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo.The crucial role of cholangiocytes in cholangiopathiesNitric oxide augments mesenchymal stem cell ability to repair liver fibrosis.Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.Bone marrow progenitor cells do not contribute to liver fibrogenic cellsHuman hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver diseaseTissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activityHDAC inhibitors in experimental liver and kidney fibrosis.Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and realityEffects of Fructus Piperis Longi extract on fibrotic liver of gamma-irradiated rats.Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats.TGF-β1 and TGF-β2 abundance in liver diseases of mice and menImmune interactions in hepatic fibrosis.Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies.Protective effects of Centella asiatica leaf extract on dimethylnitrosamine‑induced liver injury in rats.Less Smad2 is good for you! A scientific update on coffee's liver benefits.Update on the pathophysiology of liver fibrosis.Mechanisms and biomarkers of apoptosis in liver disease and fibrosis.
P2860
Q24556510-94521F0F-8C30-4942-A47B-7115D1D615F8Q24656684-5ED34CF2-DC50-46E3-B54D-4DA060FCAC3FQ26782466-0E15EEC6-C66D-4281-9A51-FDEF355359B5Q27003833-D0AE1BCD-DB1B-4318-954D-C09F734CA963Q27014616-9EA887D4-4AA6-47C7-AD53-FD2BB17CD21AQ28082569-2426A30D-0C56-42EF-9914-AF74316ACEA9Q28303698-FDBA208E-C15F-4E55-AE96-F2AFF378C2E9Q28564945-7617D05B-ECC1-46B2-B666-A68924178E7AQ30303127-A1C2E5B8-A9FF-4A91-B9A0-FF3D26CAC559Q30442460-CDB20618-56A7-4F93-9B4A-AC0AA93AA632Q30464087-D57747AD-497D-436A-8A96-95BC8E71A52CQ33236349-6B65CC55-3454-4D81-894B-5A05B1EA0488Q33386250-9A278864-26B8-4626-BB1F-678EDA5A5162Q33919037-41F7EBDD-0BA1-4D39-AA18-0B1EB0B6137DQ33976028-B26DC0CA-02F7-4957-B790-D73E071A74F8Q33990346-C1D2F849-F364-4D54-9828-CE25ED247F41Q34401307-80FD854A-9400-4995-83BA-57204BCCA660Q34992326-0D03645A-1991-4307-9563-E6EE1E355420Q35088302-2AD432A3-AAA2-4F55-89EB-358425931264Q35209239-64F0EE15-92A0-4C0A-9C49-D952C01AC4E6Q35622533-354749AB-5616-4EF1-8AD0-DA50E33EC6ABQ36018045-88CF4EE2-87E5-4A95-A12B-780DE709FCE5Q36113261-75AF3026-84B6-44E6-BFE2-D408BB272736Q36165804-85064A5F-BE51-436E-BCA4-B86D99957CD8Q36304061-D64CE4E6-E22E-4F92-82B7-2C3B9AD1B7DCQ36509141-214DF86F-EF08-4BC0-930D-BFE055462F21Q36540031-9ECFC2D9-98FB-49C0-8408-6EA258C802D7Q36579810-EE7B51AF-1612-4082-A65E-A2123DBF2C99Q36588493-07FEA18B-BD78-47CC-8C73-2895C395D5B1Q36990696-6D2822D3-0BD8-4EF9-B853-207B7691F898Q37132057-5B2F6976-B2B3-462F-AEFB-765711D770AFQ37158649-8FBF95D6-9B51-457B-98B7-15B94882FA36Q37190089-E5DCFC1D-6154-4FBC-BC8F-B43A3ABEDE6AQ37317639-A6B2164E-D5A6-4B7D-A076-473169D5ABA1Q37346066-4D66C5FA-2B14-4F5A-8110-FAC2D44AA127Q37355850-6040FAC1-0B1F-4D10-8AE7-32ABBACC855EQ37403451-3507228C-5E00-4329-B8F0-A4CFBF059935Q37554158-FB1FAEEE-D5D5-429E-BE29-9E738A455A5BQ37777155-34E9C4E6-FB3D-470F-9F40-1BDF1EF35B9FQ38008400-F456F2D3-2C2E-41D6-84E3-1E2E9A7CFE89
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Liver fibrosis: from the bench to clinical targets.
@ast
Liver fibrosis: from the bench to clinical targets.
@en
type
label
Liver fibrosis: from the bench to clinical targets.
@ast
Liver fibrosis: from the bench to clinical targets.
@en
prefLabel
Liver fibrosis: from the bench to clinical targets.
@ast
Liver fibrosis: from the bench to clinical targets.
@en
P1476
Liver fibrosis: from the bench to clinical targets.
@en
P2093
P2507
P304
P356
10.1016/J.DLD.2004.01.003
P577
2004-04-01T00:00:00Z